Previous Article
Clinical Microbiology Reviews, April 2007, p. 368-389, Vol. 20, No. 2
0893-8512/07/$08.00+0 doi:10.1128/CMR.00040-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Antimicrobial Resistance in Haemophilus influenzae
Stephen Tristram,1*
Michael R. Jacobs,2 and
Peter C. Appelbaum3
School of Human Life Science, University of Tasmania, Launceston, Australia,1
Case Western Reserve University School of Medicine, Cleveland, Ohio,2
Hershey Medical Center, Hershey, Pennsylvania3
Haemophilus influenzae is a major community-acquired pathogen causing significant morbidity and mortality worldwide. Meningitis and bacteremia due to type b strains occur in areas where the protein-conjugated type b vaccine is not in use, whereas nontypeable strains are major causes of otitis media, sinusitis, acute exacerbations of chronic bronchitis, and pneumonia. Antibiotic resistance in this organism is more diverse and widespread than is commonly appreciated. Intrinsic efflux resistance mechanisms limit the activity of the macrolides, azalides, and ketolides. ß-Lactamase production is highly prevalent worldwide and is associated with resistance to ampicillin and amoxicillin. Strains with alterations in penicillin binding proteins, particularly PBP3 (ß-lactamase negative ampicillin resistant and ß-lactamase positive amoxicillin-clavulanate resistant), are increasing in prevalence, particularly in Japan, with increasing resistance to ampicillin, amoxicillin, amoxicillin-clavulanate, and many cephalosporins, limiting the efficacy of expanded-spectrum cephalosporins against meningitis and of many oral cephalosporins against other diseases. Most strains remain susceptible to the carbapenems, which are not affected by penicillin binding protein changes, and the quinolones. The activity of many oral agents is limited by pharmacokinetics achieved with administration by this route, and the susceptibility of isolates based on pharmacokinetic and pharmacodynamic parameters is reviewed.
* Corresponding author. Mailing address: School of Human Life Sciences, University of Tasmania, Locked Bag 1320, Launceston 7250, Australia. Phone: 61 3 63 245469. Fax: 61 3 63 243995. E-mail:
Stephen.Tristram{at}utas.edu.au
Clinical Microbiology Reviews, April 2007, p. 368-389, Vol. 20, No. 2
0893-8512/07/$08.00+0 doi:10.1128/CMR.00040-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Tristram, S. G.
(2008). A comparison of Etest(R), M.I.C.EvaluatorTM strips and CLSI broth microdilution for determining {beta}-lactam antimicrobial susceptibility in Haemophilus influenzae. J Antimicrob Chemother
62: 1464-1466
[Full Text]
-
Morrissey, I., Maher, K., Williams, L., Shackcloth, J., Felmingham, D., Reynolds, R., on behalf of the BSAC Working Parties on Resistanc,
(2008). Non-susceptibility trends among Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections in the UK and Ireland, 1999-2007. J Antimicrob Chemother
62: ii97-ii103
[Abstract]
[Full Text]
-
Garcia-Cobos, S., Campos, J., Roman, F., Carrera, C., Perez-Vazquez, M., Aracil, B., Oteo, J.
(2008). Low {beta}-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae Strains Are Best Detected by Testing Amoxicillin Susceptibility by the Broth Microdilution Method. Antimicrob. Agents Chemother.
52: 2407-2414
[Abstract]
[Full Text]
-
Takahata, S., Kato, Y., Sanbongi, Y., Maebashi, K., Ida, T.
(2008). Comparison of the Efficacies of Oral {beta}-Lactams in Selection of Haemophilus influenzae Transformants with Mutated ftsI Genes. Antimicrob. Agents Chemother.
52: 1880-1883
[Abstract]
[Full Text]
-
Tristram, S. G., Pitout, M. J., Forward, K., Campbell, S., Nichols, S., Davidson, R. J.
(2008). Characterization of extended-spectrum {beta}-lactamase-producing isolates of Haemophilus parainfluenzae. J Antimicrob Chemother
61: 509-514
[Abstract]
[Full Text]
-
Kosowska-Shick, K., Clark, C., Credito, K., Dewasse, B., Beachel, L., Ednie, L., Appelbaum, P. C.
(2008). In Vitro Capability of Faropenem To Select for Resistant Mutants of Streptococcus pneumoniae and Haemophilus influenzae. Antimicrob. Agents Chemother.
52: 748-752
[Abstract]
[Full Text]
-
Tristram, S. G., Burdach, J. G.
(2007). Effect of cloned inhibitor-resistant TEM {beta}-lactamases on the susceptibility of Haemophilus influenzae to amoxicillin/clavulanate. J Antimicrob Chemother
60: 1151-1154
[Abstract]
[Full Text]